STEINERT

Clinical trials for STEINERT explained in plain language.

Never miss a new study

Get alerted when new STEINERT trials appear

Sign up with your email to follow new studies for STEINERT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental drug aims to control debilitating muscle disease

Disease control Ongoing

This global Phase 3 trial is testing whether an intravenous drug called AOC 1001 can help control symptoms of myotonic dystrophy type 1, a genetic muscle-wasting disease. About 159 adults with a confirmed diagnosis will receive either the drug or a placebo via infusion every 8 we…

Matched conditions: STEINERT

Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

STEINERT

Get alerted when new STEINERT trials appear

Experimental drug aims to control debilitating muscle disease